1.Absence of lupus anticoagulants in Behcet's disease.
Dongsik BANG ; Hye Doo JI ; Yong Seop CHOI ; Sungnack LEE
Yonsei Medical Journal 1991;32(4):326-329
The presence of a lupus anticoagulant was evaluated in patients with Bechet's disease by the kaolin clotting time method. Four percents (three patients) of 69 patients analyzed were found positive for the lupus anticoagulant. However, no statistically significant association existed between the presence of this antibody and the presence of thrombosis, clinical activity, clinical type, antinuclear antibodies and the positive VDRL test.
Behcet Syndrome/*immunology
;
Cardiolipins/immunology
;
Female
;
Human
;
Lupus Coagulation Inhibitor/*analysis
;
Male
2.Indeterminate lupus anticoagulant results: Prevalence and clinical significance.
Khaldoun ALKAYED ; Kandice KOTTKE-MARCHANT
Korean Journal of Hematology 2011;46(4):239-243
BACKGROUND: Reports of indeterminate lupus anticoagulant (LAC) results are common; however, no published data on their prevalence or clinical significance are available. We investigated the prevalence and clinical characteristics of patients with indeterminate LAC. METHODS: We retrospectively reviewed the clinical and serologic characteristics of 256 unselected patients with LAC results. RESULTS: Indeterminate results were observed in 32.7% of LAC profiles that were least frequent (25.4%) when activated partial thromboplastin time (aPTT) was normal, most frequent (39.8%) when aPTT was elevated, and were observed in 35% of patients taking warfarin. The final indeterminate LAC cohort included 65 patients with a mean follow-up of 18 months. Malignancy and autoimmune disease were present in 29% and 25% of patients, respectively. The most common thrombotic events were deep vein thrombosis (DVT) (28%), cerebral ischemic stroke (14%) and pulmonary embolism (14%). Patients with indeterminate results were more likely to be men, older, and with a history of DVT, superficial thrombosis, or myocardial infarction than patients with negative tests (N=106). Concurrent warfarin therapy was more prevalent in the indeterminate group, but was not statistically significant. In the multivariate analysis, none of the variables showed statistical significance. During follow-up, 10 of 16 patients with indeterminate results showed change in classification upon retesting. CONCLUSION: Patients with indeterminate LAC results were common, and their clinical characteristics differed from those with negative results. There is a need for a prospective study of the clinical history of patients with indeterminate LAC results.
Antibodies, Antiphospholipid
;
Antiphospholipid Syndrome
;
Autoimmune Diseases
;
Cohort Studies
;
Follow-Up Studies
;
Humans
;
Lupus Coagulation Inhibitor
;
Male
;
Multivariate Analysis
;
Myocardial Infarction
;
Partial Thromboplastin Time
;
Prevalence
;
Pulmonary Embolism
;
Retrospective Studies
;
Stroke
;
Thrombosis
;
Venous Thrombosis
;
Warfarin
3.Usefulness of Silica Clotting Time for Detection of Lupus Anticoagulants.
Hye Ryun LEE ; Ji Eun KIM ; Soo Hyun HA ; Hyun Kyung KIM ; Seonyang PARK ; Han Ik CHO
The Korean Journal of Laboratory Medicine 2009;29(6):497-504
BACKGROUND: The presence of lupus anticoagulants (LA) is a strong risk factor for thrombosis in antiphospholipid syndrome. We investigated the usefulness of addition of silica clotting time (SCT) to the pre-existing dilute Russell's viper venom test (dRVVT) for detection of LA. Also, we analyzed differences in the thrombotic features and the characteristics of antiphospholipid antibodies between dRVVT and SCT. METHODS: A total of 167 patients positive for LA or anti-cardiolipin (anti-CL) antibody and 76 healthy controls were enrolled. The dRVVT and SCT were used for detection of LA. Anti-CL, anti-beta2-glycoprotein I (anti-beta2 GPI) and anti-prothrombin (anti-PT) antibodies were measured using commercial ELISA kits. RESULTS: In detection of thrombosis, the sensitivity of the combined test of SCT and dRVVT was 56.4%, which was higher than that of dRVVT alone (46.2%) or SCT alone (23.1%). The specificity of the combined test (80.9%) was comparable to that of dRVVT (81.9%). Also, odds ratio for predicting thrombosis was higher in the combined test than in dRVVT or SCT alone. When normalized LA ratio of the two tests was compared, the group of patients with higher ratio of SCT showed significantly higher prevalence of recurrent abortion and higher positivity of IgG types of anti-CL, anti-beta2 GPI and anti-PT than the group with higher ratio of dRVVT. CONCLUSIONS: Addition of SCT to dRVVT can improve the detection sensitivity of thrombosis in LA test. And the high normalized LA ratio of SCT may be a useful parameter for detection of recurrent abortion.
Adult
;
Aged
;
Antibodies, Anticardiolipin/analysis
;
Antibodies, Antiphospholipid/analysis
;
Blood Coagulation Tests/*methods
;
Female
;
Humans
;
Immunoglobulin G/analysis
;
Immunoglobulin M/analysis
;
Lupus Coagulation Inhibitor/*blood
;
Male
;
Middle Aged
;
Prothrombin/immunology
;
Prothrombin Time/methods
;
Reagent Kits, Diagnostic
;
Sensitivity and Specificity
;
Silicon Dioxide/*chemistry
;
Thrombosis/diagnosis
;
beta 2-Glycoprotein I/immunology